A blinded, randomized controlled trial of neo-adjuvant celecoxib in patients with early prostate cancer. (JOURNAL OF CLINICAL ONCOLOGY, 2006)

(untitled) - Sooriakumaran, P; Macanas-Pirard, P; Fox, S; Coley, H; Bucca, G; Lovell, D; Henderson, A; Smith, C; Langley, S; Laing, R